Insulet
PODD
186 hedge funds and large institutions have $2.91B invested in Insulet in 2014 Q1 according to their latest regulatory filings, with 43 funds opening new positions, 56 increasing their positions, 68 reducing their positions, and 16 closing their positions.
169% more first-time investments, than exits
New positions opened: 43 | Existing positions closed: 16
80% more funds holding in top 10
Funds holding in top 10: 5 → 9 (+4)
70% more call options, than puts
Call options by funds: $6.21M | Put options by funds: $3.65M
27% more capital invested
Capital invested by funds: $2.29B → $2.91B (+$621M)
14% more funds holding
Funds holding: 163 → 186 (+23)
18% less repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 68
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$39.4M |
| 2 |
GA
Geneva Advisors
Chicago,
Illinois
|
+$21.5M |
| 3 |
TA
Teachers Advisors
New York
|
+$20.7M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$13.9M |
| 5 |
MACM
March Altus Capital Management
Greenwich,
Connecticut
|
+$12M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
-$42.2M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$30.3M |
| 3 |
SCA
SAC Capital Advisors
Stamford,
Connecticut
|
-$26.7M |
| 4 |
BAMCO Inc
New York
|
-$24.1M |
| 5 |
Jennison Associates
New York
|
-$20.3M |
PODD Hedge Fund Activity: Q1 2014 in Review
186 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in Insulet (PODD) for Q1 2014, worth a combined $2.91B — up 27% from $2.29B a quarter earlier.
Buyers outnumbered sellers: 43 funds opened new PODD positions and 16 closed out — a net gain of 27 holders — while 56 added to existing stakes and 68 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $39.4M. The largest seller was OrbiMed, cutting an estimated $42.2M.
- 186 institutional investors held Insulet (PODD) as of Q1 2014, up from 163 in Q4 2013.
- Funds reported $2.91B of Insulet stock for Q1 2014, up 27% quarter-over-quarter.
- 43 funds opened new Insulet positions in Q1 2014 and 16 closed out, a net change of +27 holders.
- The largest Insulet buyer in Q1 2014 was Wellington Management Group, an estimated $39.4M added.
- The largest Insulet seller in Q1 2014 was OrbiMed, an estimated $42.2M sold.
Based on aggregated 13F filings for Q1 2014.